Gilead Sciences (GILD) Preferred Stock Liabilities (2012 - 2015)

Gilead Sciences has reported Preferred Stock Liabilities for 4 years, with the latest figure at $2.0 million in Q4 2015.

• For the quarter ending Q4 2015, Preferred Stock Liabilities fell 86.67% year-over-year to $2.0 million; the trailing twelve-month figure through Dec 2015 stood at $2.0 million (down 86.67% YoY), and the FY2015 full-year result was $2.0 million, down 86.67% from the prior year.
• Preferred Stock Liabilities for Q4 2015 stood at $2.0 million, down from $4.0 million in the prior quarter.
• The five-year high for Preferred Stock Liabilities was $64.0 million in Q4 2013, with the low at $2.0 million in Q4 2015.
• Historically, Preferred Stock Liabilities has averaged $21.9 million across 4 years, with a median of $13.0 million in 2014.
• Annual changes were most pronounced in 2013 — Preferred Stock Liabilities surged 795.48% — and 2015, when it sank 86.67%.
• Gilead Sciences' Preferred Stock Liabilities stood at $7.1 million in 2012, then jumped by 795.48% to $64.0 million in 2013, then sank by 76.56% to $15.0 million in 2014, then slumped by 86.67% to $2.0 million in 2015.
• The last three Preferred Stock Liabilities figures came in at $2.0 million (Q4 2015), $4.0 million (Q3 2015), and $7.0 million (Q2 2015), per Business Quant data.